-
Something wrong with this record ?
Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants
AS. Bhagavathula, B. Woolf, J. Rahmani, K. Vidyasagar, W. Tesfaye
Language English Country Germany
Document type Letter, Systematic Review, Comment
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
CINAHL Plus with Full Text (EBSCOhost)
from 2008-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1997-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Carcinoma, Hepatocellular * epidemiology MeSH
- Serotonin and Noradrenaline Reuptake Inhibitors * MeSH
- Cohort Studies MeSH
- Humans MeSH
- Liver Neoplasms * chemically induced epidemiology MeSH
- Selective Serotonin Reuptake Inhibitors adverse effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
- Systematic Review MeSH
Department of Psychological Sciences University of Bristol Bristol BS8 1TH UK
Health Research Institute University of Canberra Canberra Australia
Sydney Pharmacy School The University of Sydney Camperdown Sydney NSW Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017882
- 003
- CZ-PrNML
- 005
- 20220804134436.0
- 007
- ta
- 008
- 220720s2022 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00228-022-03309-y $2 doi
- 035 __
- $a (PubMed)35274148
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Bhagavathula, Akshaya Srikanth $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy at Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. akshaypharmd@gmail.com
- 245 10
- $a Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants / $c AS. Bhagavathula, B. Woolf, J. Rahmani, K. Vidyasagar, W. Tesfaye
- 650 12
- $a hepatocelulární karcinom $x epidemiologie $7 D006528
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory jater $x chemicky indukované $x epidemiologie $7 D008113
- 650 _2
- $a selektivní inhibitory zpětného vychytávání serotoninu $x škodlivé účinky $7 D017367
- 650 12
- $a inhibitory zpětného vychytávání serotoninu a noradrenalinu $7 D000068760
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a komentáře $7 D016420
- 700 1_
- $a Woolf, Benjamin $u Department of Psychological Sciences, University of Bristol, Bristol, BS8 1TH, UK
- 700 1_
- $a Rahmani, Jamal $u Department of Community Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Vidyasagar, Kota $u Department of Pharmaceutical Sciences, University College of Pharmaceutical Sciences, Hanamkonda, 506009, Telangana, India
- 700 1_
- $a Tesfaye, Wubshet $u Health Research Institute, University of Canberra, Canberra, Australia. wubshet.tesfaye@sydney.edu.au $u Sydney Pharmacy School, The University of Sydney, Camperdown, Sydney, NSW, Australia. wubshet.tesfaye@sydney.edu.au $1 https://orcid.org/0000000172082330
- 773 0_
- $w MED00001613 $t European journal of clinical pharmacology $x 1432-1041 $g Roč. 78, č. 7 (2022), s. 1199-1200
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35274148 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134430 $b ABA008
- 999 __
- $a ok $b bmc $g 1821803 $s 1169125
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 78 $c 7 $d 1199-1200 $e 20220311 $i 1432-1041 $m European journal of clinical pharmacology $n Eur J Clin Pharmacol $x MED00001613
- LZP __
- $a Pubmed-20220720
